Skip to main content

Table 4 Multiple linear regression analysis of ΔEPCs with Δ value of other clinical parameters in the MET-DUL group

From: Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus

Variables

β

SE

t value

P value

95% CI

ΔBMI

− 0.217

0.097

− 3.328

0.019

− 0.351 to − 0.892

ΔNO

0.496

0.227

7.591

< 0.001

1.195 to 2.767

ΔCRP

− 0.198

0.116

− 2.793

0.042

− 0.184 to − 0.901

ΔIL-6

− 0.294

0.102

− 4.985

0.008

− 0.271 to − 0.849

ΔAGEs

− 0.227

0.175

− 3.849

0.025

− 0.327 to − 0.923

  1. MET-DUL metformin combined with dulaglutide treatment group, EPCs endothelial progenitor cells, BMI body mass index, NO nitric oxide, CRP C-reactive protein, IL-6 interleukin-6, AGEs advanced glycation end products, ∆ the change value of various index before and after treatment
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840